394 related articles for article (PubMed ID: 29144509)
1. Circular RNA expression is suppressed by androgen receptor (AR)-regulated adenosine deaminase that acts on RNA (ADAR1) in human hepatocellular carcinoma.
Shi L; Yan P; Liang Y; Sun Y; Shen J; Zhou S; Lin H; Liang X; Cai X
Cell Death Dis; 2017 Nov; 8(11):e3171. PubMed ID: 29144509
[TBL] [Abstract][Full Text] [Related]
2. ADAR1 p110 Enhances Adhesion of Tumor Cells to Extracellular Matrix in Hepatocellular Carcinoma via Up-Regulating ITGA2 Expression.
Yu J; Zhang C; Yu Q; Yu H; Zhang B
Med Sci Monit; 2019 Feb; 25():1469-1479. PubMed ID: 30798327
[TBL] [Abstract][Full Text] [Related]
3. CDK13 RNA Over-Editing Mediated by ADAR1 Associates with Poor Prognosis of Hepatocellular Carcinoma Patients.
Dong X; Chen G; Cai Z; Li Z; Qiu L; Xu H; Yuan Y; Liu XL; Liu J
Cell Physiol Biochem; 2018; 47(6):2602-2612. PubMed ID: 29996118
[TBL] [Abstract][Full Text] [Related]
4. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma.
Chan TH; Lin CH; Qi L; Fei J; Li Y; Yong KJ; Liu M; Song Y; Chow RK; Ng VH; Yuan YF; Tenen DG; Guan XY; Chen L
Gut; 2014 May; 63(5):832-43. PubMed ID: 23766440
[TBL] [Abstract][Full Text] [Related]
5. Loss of androgen receptor promotes HCC invasion and metastasis via activating circ-LNPEP/miR-532-3p/RAB9A signal under hypoxia.
Ouyang X; Yao L; Liu G; Liu S; Gong L; Xiao Y
Biochem Biophys Res Commun; 2021 Jun; 557():26-32. PubMed ID: 33862456
[TBL] [Abstract][Full Text] [Related]
6. The RNA-binding protein RBM3 promotes cell proliferation in hepatocellular carcinoma by regulating circular RNA SCD-circRNA 2 production.
Dong W; Dai ZH; Liu FC; Guo XG; Ge CM; Ding J; Liu H; Yang F
EBioMedicine; 2019 Jul; 45():155-167. PubMed ID: 31235426
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma.
Yu J; Xu QG; Wang ZG; Yang Y; Zhang L; Ma JZ; Sun SH; Yang F; Zhou WP
J Hepatol; 2018 Jun; 68(6):1214-1227. PubMed ID: 29378234
[TBL] [Abstract][Full Text] [Related]
8. Screening and bioinformatics analysis of circular RNA expression profiles in hepatitis B-related hepatocellular carcinoma.
Wang S; Cui S; Zhao W; Qian Z; Liu H; Chen Y; Lv F; Ding HG
Cancer Biomark; 2018; 22(4):631-640. PubMed ID: 29914004
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA hsa_circ_103809 suppresses hepatocellular carcinoma proliferation and invasion by sponging miR-620.
Li X; Shen M
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(2):555-566. PubMed ID: 30720163
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA 101368/miR-200a axis modulates the migration of hepatocellular carcinoma through HMGB1/RAGE signaling.
Li S; Gu H; Huang Y; Peng Q; Zhou R; Yi P; Chen R; Huang Z; Hu X; Huang Y; Tang D
Cell Cycle; 2018; 17(19-20):2349-2359. PubMed ID: 30265210
[TBL] [Abstract][Full Text] [Related]
11. Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma.
Chen Y; Ling Z; Cai X; Xu Y; Lv Z; Man D; Ge J; Yu C; Zhang D; Zhang Y; Xie H; Zhou L; Wu J; Zheng S
Cancer Res; 2022 Feb; 82(4):599-614. PubMed ID: 34916222
[TBL] [Abstract][Full Text] [Related]
12. CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth.
Xu L; Feng X; Hao X; Wang P; Zhang Y; Zheng X; Li L; Ren S; Zhang M; Xu M
J Exp Clin Cancer Res; 2019 Feb; 38(1):98. PubMed ID: 30795787
[TBL] [Abstract][Full Text] [Related]
13. ADAR1 promotes HBV replication through its deaminase domain.
Yuan L; Jia Q; Yang S; Idris NFB; Li Y; Wang Y; Zhao Y; Hu J; Hu Y; Huang A; Tu Z
Front Biosci (Landmark Ed); 2020 Jan; 25(4):710-721. PubMed ID: 31585913
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor affects the response to immune checkpoint therapy by suppressing PD-L1 in hepatocellular carcinoma.
Jiang G; Shi L; Zheng X; Zhang X; Wu K; Liu B; Yan P; Liang X; Yu T; Wang Y; Cai X
Aging (Albany NY); 2020 Jun; 12(12):11466-11484. PubMed ID: 32579541
[TBL] [Abstract][Full Text] [Related]
15. RNA editing enzyme ADAR1 controls miR-381-3p-mediated expression of multidrug resistance protein MRP4 via regulation of circRNA in human renal cells.
Omata Y; Okawa M; Haraguchi M; Tsuruta A; Matsunaga N; Koyanagi S; Ohdo S
J Biol Chem; 2022 Aug; 298(8):102184. PubMed ID: 35753353
[TBL] [Abstract][Full Text] [Related]
16. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway.
Yu J; Yang M; Zhou B; Luo J; Zhang Z; Zhang W; Yan Z
Clin Sci (Lond); 2019 Jul; 133(13):1487-1503. PubMed ID: 31278132
[TBL] [Abstract][Full Text] [Related]
17. hsa_circ_0091570 acts as a ceRNA to suppress hepatocellular cancer progression by sponging hsa-miR-1307.
Wang YG; Wang T; Ding M; Xiang SH; Shi M; Zhai B
Cancer Lett; 2019 Sep; 460():128-138. PubMed ID: 31207319
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor suppresses vasculogenic mimicry in hepatocellular carcinoma via circRNA7/miRNA7-5p/VE-cadherin/Notch4 signalling.
Bao S; Jin S; Wang C; Tu P; Hu K; Lu J
J Cell Mol Med; 2020 Dec; 24(23):14110-14120. PubMed ID: 33118329
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA hsa_circ_0016788 regulates hepatocellular carcinoma tumorigenesis through miR-486/CDK4 pathway.
Guan Z; Tan J; Gao W; Li X; Yang Y; Li X; Li Y; Wang Q
J Cell Physiol; 2018 Jan; 234(1):500-508. PubMed ID: 29923236
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression.
Wang L; Long H; Zheng Q; Bo X; Xiao X; Li B
Mol Cancer; 2019 Jul; 18(1):119. PubMed ID: 31324186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
